Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis
Immune checkpoint inhibitor (ICI)-induced colitis is one of the known complications of therapies targeting cytotoxic programmed cell death protein 1 (PD-1), cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), and programmed cell death ligand 1 (PD-L1). ICI-associated colitis is routinely treated w...
| Main Authors: | , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Frontiers Media S.A.
2022-06-01
|
| סדרה: | Frontiers in Oncology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fonc.2022.925964/full |